Those observations demonstrated that silencing of CDR1as in vivo can increase the chemosensitivity of BC resistant cells to 5‐Fu and inhibiting on miR‐7 can reverse the effect on chemosensitivity of 5‐FU‐resistant BC cells caused by silence of CDR1as. Here, LINC00632 is linked to breast cancer.